Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchioloalveolar carcinoma: a review.

Dan J Raz1, Biao He, Rafael Rosell

  • 1Department of Surgery, University of California, San Francisco, CA 94131, USA. dan.raz@ucsf.edu

Clinical Lung Cancer
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Scoping Review of Malnutrition Risk Prediction Models in Cancer Patients.

Journal of clinical nursing·2026
Same author

<i>CFTR</i> gene delivery to human airway epithelia using parainfluenza virus 5 amplifying virus-like particles.

Molecular therapy. Nucleic acids·2026
Same author

Identification of β-Lapachone as a Potent USP22 Inhibitor That Suppresses Cancer Stemness and Enhances Chemosensitivity in Lung Adenocarcinoma.

International journal of molecular sciences·2026
Same author

T-Bet Modulates Plasmodium-Specific CD4<sup>+</sup> T Cell Differentiation and Anti-Malarial Immunity During Blood-Stage Infection.

Parasite immunology·2026
Same author

A dual-channel electron expressway triggers piezocatalytic ferroptosis-mitochondrial catastrophe cascade for anti-glioblastoma therapy.

Biomaterials·2026
Same author

Enhanced Energy Storage Performance in Mn-Doped BaTiO<sub>3</sub>-Based Epitaxial Thin Films.

ACS applied materials & interfaces·2026

Bronchioloalveolar carcinoma (BAC), a lung adenocarcinoma subtype, presents uniquely and affects specific demographics. While surgery is curative for resectable cases, targeted therapies show promise for unresectable BAC.

Area of Science:

  • Oncology
  • Pulmonology
  • Pathology

Background:

  • Bronchioloalveolar carcinoma (BAC) is a distinct subtype of lung adenocarcinoma with unique clinical and biological features.
  • It disproportionately affects women, never-smokers, and Asians, often presenting as small, incidentally detected lesions.

Purpose of the Study:

  • To delineate the distinct characteristics of BAC compared to other non-small-cell lung carcinoma (NSCLC) subtypes.
  • To review the diagnostic, therapeutic, and prognostic implications of BAC histology.

Main Methods:

  • Review of existing literature on Bronchioloalveolar carcinoma.
  • Comparative analysis of BAC with other non-small-cell lung carcinoma subtypes regarding demographics, tumor biology, and treatment response.

Related Experiment Videos

Main Results:

  • BAC exhibits distinct growth patterns along alveolar septae without invasion and is increasingly recognized, especially in mixed histology with adenocarcinoma.
  • Surgical resection remains the primary curative treatment for resectable BAC.
  • Unresectable BAC patients show a higher response rate to epidermal growth factor receptor tyrosine kinase inhibitors (gefitinib, erlotinib) compared to other NSCLC subtypes.

Conclusions:

  • BAC is a unique lung cancer entity with specific risk factors and presentation.
  • While offering a potentially better long-term survival rate, BAC may also carry an increased risk of intrathoracic recurrence.
  • Targeted therapies represent a significant advancement for unresectable BAC management.